ICAM3-Fc Outperforms Receptor-Specific Antibodies Targeted Nanoparticles to Dendritic Cells for Cross-Presentation

Optimal targeting of nanoparticles (NP) to dendritic cells (DCs) receptors to deliver cancer-specific antigens is key to the efficient induction of anti-tumour immune responses. Poly (lactic-co-glycolic acid) (PLGA) nanoparticles containing tètanus toxoid and gp100 melanoma-associated antigen, toll-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Luis J., Tacken, Paul J., van der Schoot, Johan M.S., Rueda, Felix, Torensma, Ruurd, Figdor, Carl G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540027/
https://www.ncbi.nlm.nih.gov/pubmed/31083610
http://dx.doi.org/10.3390/molecules24091825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540027/
https://www.ncbi.nlm.nih.gov/pubmed/31083610
http://dx.doi.org/10.3390/molecules24091825

Ejemplares similares